Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-11

Clinical Trial Update: A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED) [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 trial evaluating the efficacy and tolerability of Remicade (infliximab) in patients with active ankylosing spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Spondylitis, Ankylosing | Phase 4 | Status: COMPLETED